Marshall Wace North America’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $20.7M | Buy |
+112,359
| New | +$20.7M | 0.09% | 230 |
|
|
2021
Q2 | – | Sell |
-272,286
| Closed | -$45.5M | – | 1733 |
|
|
2021
Q1 | $45.5M | Sell |
272,286
-38,023
| -12% | -$6.36M | 0.19% | 126 |
|
|
2020
Q4 | $47.1M | Sell |
310,309
-70,737
| -19% | -$10.7M | 0.21% | 123 |
|
|
2020
Q3 | $38.5M | Buy |
381,046
+62,710
| +20% | +$6.33M | 0.25% | 102 |
|
|
2020
Q2 | $38.5M | Buy |
318,336
+287,192
| +922% | +$34.8M | 0.25% | 103 |
|
|
2020
Q1 | $2.95M | Buy |
+31,144
| New | +$2.95M | 0.02% | 412 |
|
|
2019
Q3 | – | Sell |
-7,772
| Closed | -$606K | – | 1567 |
|
|
2019
Q2 | $606K | Buy |
+7,772
| New | +$606K | ﹤0.01% | 854 |
|
|
2019
Q1 | – | Sell |
-12,327
| Closed | -$1.34M | – | 1916 |
|
|
2018
Q4 | $1.34M | Buy |
+12,327
| New | +$1.34M | 0.01% | 541 |
|
|
2018
Q3 | – | Sell |
-3,154
| Closed | -$357K | – | 1383 |
|
|
2018
Q2 | $357K | Buy |
+3,154
| New | +$357K | ﹤0.01% | 1145 |
|
|
2017
Q4 | – | Sell |
-31,964
| Closed | -$3.74M | – | 1627 |
|
|
2017
Q3 | $3.74M | Buy |
+31,964
| New | +$3.74M | 0.02% | 629 |
|
|
2017
Q2 | – | Sell |
-70,630
| Closed | -$9.54M | – | 1473 |
|
|
2017
Q1 | $9.54M | Buy |
+70,630
| New | +$9.54M | 0.08% | 282 |
|
|
2013
Q4 | $214K | Buy |
+1,891
| New | +$214K | ﹤0.01% | 634 |
|